leading the field of in vivo immune cell reprogramming. We are pursuing products that modulate immune cells from within their native environment to enhance patient access and patient outcomes.
Investors 3
| Date | Name | Website |
| - | Tech Coast... | techcoasta... |
| - | SeedFolio | seedfolio.... |
| - | Biobrit | biobrit.co... |